Recent

% | $
Quotes you view appear here for quick access.

Celgene Corporation Message Board

  • drmiller355 drmiller355 Jan 11, 2013 12:01 PM Flag

    3 More New Blockbusters Drugs Coming 2013- 12 Billion Revenue. Read

    Seeking Alpha Market Currents
    Celgene Corp. (CELG +3.1%) updates guidance, saying it expects FY12 income to come in at the higher end of previous estimates and in-line results for 2013. Net product sales are expected to double between 2013 and 2017, reaching over $12B, with numerous milestones expected in 2013 for three "potential blockbuster" drugs. One of the drugs is its existing cancer drug Abraxane, which it hopes to have approved as a treatment for pancreatic cancer - which is among the hardest to treat - sometime this year.

 
CELG
124.04+1.00(+0.81%)Aug 28 4:00 PMEDT